Estrogen Receptor Positive and Progesterone Receptor Negative Breast Cancer: the Role of Hormone Therapy-Reference-Cited by-同舟云学术

Estrogen Receptor Positive and Progesterone Receptor Negative Breast Cancer: the Role of Hormone Therapy

Published:2020-06-09 Issue:3-4 Volume:11 Page:148-154
ISSN:1868-8497
Container-title:Hormones and Cancer
language:en
Short-container-title:HORM CANC

Author:

Dembinski Robert,Prasath Vishnu,Bohnak Carisa,Siotos Charalampos,Sebai Mohamad E.,Psoter Kevin,Gani Faiz,Canner Joe,Camp Melissa S.,Azizi Armina,Jacobs Lisa,Habibi Mehran^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Endocrine and Autonomic Systems,Endocrinology,Oncology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12672-020-00387-1.pdf

Reference37 articles.

1. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin. 69(1):7–34

2. Arpino G et al (2005) Estrogen receptor–positive, progesterone receptor–negative breast cancer: association with growth factor receptor expression and Tamoxifen Resistance. J Natl Cancer Inst. 97(17):1254–1261

3. Clark GM, McGuire WL (1988) Steroid receptors and other prognostic factors in primary breast cancer. Semin Oncol. 15:20–25

4. Bae SY et al (2015) Poor prognosis of single hormone receptor-positive breast cancer: similar outcome as triple-negative breast cancer. BMC Cancer. 15(1):138

5. Clahsen PC et al (1999) The utility of mitotic index, estrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer. Eur J Surg Oncol. 25(4):356–363.s

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological Evaluation of Patients with Hormone Receptor–Positive HER2-Negative Metastatic Breast Cancer Progressing on Endocrine Treatment: A Real-World Retrospective Study from a Regional Cancer Center;South Asian Journal of Cancer;2023-12-08

2. Hormone receptors in breast cancer: An update on the uncommon subtypes;Pathology - Research and Practice;2023-10

3. FOXC1 and SOX10 in Estrogen Receptor–Low Positive/HER2-Negative Breast Cancer: Potential Biomarkers for the Basal-like Phenotype Prediction;Archives of Pathology & Laboratory Medicine;2023-06-28

4. Potential miRNA Use as a Biomarker: From Breast Cancer Diagnosis to Metastasis;Cells;2023-02-06

5. Long non-coding RNAs affecting cell metabolism in cancer;Biology Direct;2022-10-01